Wei Dong Yu

SPH Xing Ling Sci. & Tech. Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese and natural medicines. Its products include ginkgo ketone ester capsules, ginkgo biloba raw materials, and Chinese medicine raw materials. The company was founded on June 10, 1992 and is headquartered in Shanghai, China.

Chongqing Shangyao Huiyuan Pharmaceutical Co. Ltd. engages in the Trading of traditional Chinese medicine raw materials. Its business scope includes production of Chinese herbal and toxic Chinese herbal medicine; wholesale and retail of pre-packaged food and bulk food; wholesale of chemical raw materials and their preparations, antibiotic raw materials and their preparations, biochemical drugs, proprietary Chinese medicines, Chinese herbal medicines, and biological products; Chinese herbal medicine planting; acquisition of Chinese herbal medicines; acquisition of toxic Chinese herbal medicines; sales of Chinese herbal medicines; and sales of toxic Chinese herbal medicines. The company was founded on December 13, 1985 and is headquartered in Chongqing, China.

Part of Shanghai Pharmaceuticals Holding Co., Ltd., SPH Keyuan Xinhai Pharmaceutical Co., Ltd. is a pharmaceutical company based in Haikou, China. The Chinese company manufactures and distributes pharmaceutical products. The private company was founded in 1993. The CEO is Rui Yu. SPH Keyuan Xinhai Pharmaceutical Co. was acquired by China Health System Ltd., a SUB of Shanghai Pharmaceuticals Holding Co., Ltd. from CITIC Ltd. on January 18, 2007 for $8.12 million.